https://galimedix.com/references/the-small-molecule-gal-201-efficiently-detoxifies-soluble-amyloid-%ce%b2-oligomers-new-approach-towards-oral-disease-modifying-treatment-of-alzheimers-disease/ 2023-10-13T09:30:37+00:00 https://galimedix.com/references/improved-sensitivity-of-microperimetric-outcomes-for-clinical-studies-in-age-related-macular-degeneration/ 2023-10-13T09:31:30+00:00 https://galimedix.com/abstracts/sustained-neuroprotective-effect-of-novel-a%ce%b2-aggregation-modulator-gal-101-shown-in-dry-amd-and-glaucoma-models-with-transient-peak-concentrations-using-eye-drops/ 2023-10-13T09:43:04+00:00 https://galimedix.com/abstracts/gal-101-prevents-%ce%b2-amyloid-induced-membrane-depolarization-in-two-different-types-of-retinal-cells-poster-presentation/ 2023-10-16T05:32:25+00:00 https://galimedix.com/references/mrz-99030-a-novel-modulator-of-a%ce%b2-aggregation-i-mechanism-of-action-moa-underlying-the-potential-neuroprotective-treatment-of-alzheimers-disease-glaucoma-and-age-related-macular-degener/ 2023-10-16T05:40:04+00:00 https://galimedix.com/references/effect-of-the-a%ce%b2-aggregation-modulator-mrz-99030-on-retinal-damage-in-an-animal-model-of-glaucoma/ 2023-10-16T05:41:45+00:00 https://galimedix.com/references/the-a%ce%b2-aggregation-modulator-mrz-99030-prevents-and-even-reverses-synaptotoxic-effects-of-a%ce%b21-42-on-ltp-even-following-serial-dilution-to-a-5001-stoichiometric-excess-of-a%ce%b21-42-sugges/ 2023-10-16T05:42:11+00:00 https://galimedix.com/references/visual-field-endpoints-based-on-subgroups-of-points-may-be-useful-in-glaucoma-clinical-trials-a-study-with-the-humphrey-field-analyzer-and-compass-perimeter/ 2023-10-16T05:42:39+00:00 https://galimedix.com/in-the-news/bioworld/ 2023-10-16T10:24:37+00:00 https://galimedix.com/in-the-news/pharmafocus/ 2023-10-16T10:37:46+00:00 https://galimedix.com/references/mrz-99030-a-novel-modulator-of-a%ce%b2-aggregation-ii-reversal-of-a%ce%b2-oligomer-induced-deficits-in-long-term-potentiation-ltp-and-cognitive-performance-in-rats-and-mice/ 2023-10-16T10:40:38+00:00 https://galimedix.com/in-the-news/going-public/ 2024-02-09T06:43:28+00:00 https://galimedix.com/in-the-news/scrip/ 2024-02-09T06:44:29+00:00 https://galimedix.com/references/molecular-insights-into-the-inhibition-of-early-stages-of-a%ce%b2-peptide-aggregation-and-destabilization-of-alzheimers-a%ce%b2-protofibril-by-dipeptide-d-trp-aib-a-molecular-modelling-appro/ 2024-07-04T07:26:13+00:00 https://galimedix.com/references/cognitive-performance-recovery-of-alzheimers-disease-model-mice-by-modulation-of-early-soluble-amyloidal-assembliesd-trp-aib-refers-to-the-same-compound-as-gal-101/ 2024-07-05T07:33:28+00:00 https://galimedix.com/references/gal-101-prevents-amyloid-beta-induced-membrane-depolarization-in-two-different-types-of-retinal-cells/ 2025-01-22T08:57:42+00:00 https://galimedix.com/abstracts/the-amyloid-beta-aggregation-modulator-gal-201-is-under-development-for-oral-ad-treatment-cognitive-improvement-in-a-transgenic-ad-model/ 2025-03-31T14:00:27+00:00 https://galimedix.com/abstracts/small-molecule-gal-201-under-development-for-oral-ad-treatment-modulation-of-a%ce%b2-aggregation-directly-influences-synaptic-plasticity-and-also-affects-neuroinflammation/ 2025-04-01T06:59:26+00:00 https://galimedix.com/references/gal-201-as-a-promising-amyloid-%ce%b2-targeting-small-molecule-approach-for-alzheimers-disease-treatment/ 2025-04-28T07:14:24+00:00 https://galimedix.com/in-the-news/drug-discovery-news/ 2025-07-18T05:53:59+00:00 https://galimedix.com/in-the-news/scrip-asks/ 2025-07-18T05:55:33+00:00 https://galimedix.com/in-the-news/medicine-maker/ 2025-07-18T11:21:39+00:00 https://galimedix.com/multimedia/archive/ 2025-07-30T06:50:00+00:00 https://galimedix.com/wp-content/uploads/2024/06/Video_Screenshot_new.png https://galimedix.com/wp-content/uploads/2024/06/Video_Screenshot_new.png https://galimedix.com/wp-content/uploads/2024/06/Video_Screenshot_new.png https://galimedix.com/wp-content/uploads/2024/06/Video_Screenshot_new.png https://galimedix.com/wp-content/uploads/2024/06/Video_Screenshot_new.png https://galimedix.com/wp-content/uploads/2024/06/Video_Screenshot_new.png https://galimedix.com/wp-content/uploads/2024/06/Video_Screenshot_new.png https://galimedix.com/abstracts/innovations-in-edream-a-phase-2-clinical-trial-in-geographic-atrophy/ 2025-09-05T10:12:47+00:00 https://galimedix.com/in-the-news/fierce-biotech/ 2025-09-24T07:11:57+00:00 https://galimedix.com/abstracts/stopping-neurodegeneration-at-its-source-with-gal-101/ 2025-12-04T19:15:25+00:00 https://galimedix.com/abstracts/a-new-oral-prodrug-of-the-a%ce%b2-aggregation-modulator-gal-201-shows-significantly-improved-pharmacokinetic-profile/ 2026-03-20T07:00:10+00:00 https://galimedix.com/in-the-news/pharmavoice/ 2026-08-05T07:44:09+00:00